Acly-flox Mouse
Common Name
Acly-flox
제품 ID
S-CKO-18547
Backgroud
C57BL/6NCya
품종 계통계통 ID
CKOCMP-104112-Acly-B6N-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Acly-flox Mouse (카탈로그 번호 S-CKO-18547)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Acly-flox
품종 계통계통 ID
CKOCMP-104112-Acly-B6N-VA
유전자명
제품 ID
S-CKO-18547
유전자 별칭
A730098H14Rik
배경
C57BL/6NCya
유전자 공식 전체 명칭
ATP citrate lyase
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 11
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000007131
NCBI 전사체 ID
NM_134037
타겟 영역
Exon 4~6
유효 영역 크기
~2.5kb
유전자 연구 개요
Acly, also known as adenosine 5'-triphosphate citrate lyase, is a cytosolic enzyme that plays a crucial role in cellular metabolism. It converts citrate into acetyl-coenzyme A, which is an essential precursor for fatty acid and cholesterol biosynthesis [1,2]. This enzyme links carbohydrate to lipid metabolism, and its activity impacts various biological processes such as cell growth, division, and immunomodulation. Genetic models, like KO/CKO mouse models, have been instrumental in studying Acly's functions.
In cancer research, inhibition of Acly in immunocompetent mice was found to up-regulate PD-L1 expression in cancer cells, leading to T cell dysfunction and immunosuppression. However, it also overcame cancer resistance to anti-PD-L1 therapy in a cGAS-dependent manner, likely through polyunsaturated fatty acid peroxidation and mitochondrial damage that activate the cGAS-STING pathway [1].
In hepatocytes, Acly deficiency protected from hepatic steatosis and dyslipidemia, and pharmacological inhibition of Acly by bempedoic acid prevented dyslipidemia and attenuated atherosclerosis in hypercholesterolemic mouse models [2].
In colon cancer cell lines, ACLY-deficient cells showed attenuated migration and invasion abilities, and in a mouse model, ACLY was shown to promote metastasis by stabilizing CTNNB1 protein [3].
In the context of non-alcoholic fatty liver disease (NAFLD), Hrd1, a subunit of the endoplasmic reticulum-associated degradation complex, interacted with and ubiquitinated Acly in db/db mice, reducing its protein level and suppressing lipogenesis [4].
In liver ischemia-reperfusion injury, hepatocyte-specific knockout of Acly exacerbated injury, while restoring Acly nuclear localization in steatotic livers ameliorated the injury [5].
In mucosal T cells, ACLY-deficient CD4+ T cells had an impaired capacity to induce intestinal inflammation in a transfer colitis model, and modulation of ACLY expression in T cells could be a strategy to resolve intestinal inflammation [6].
In conclusion, Acly is essential for lipid metabolism, playing a significant role in various disease conditions such as cancer, atherosclerosis, NAFLD, and colitis. Gene knockout and conditional knockout mouse models have been crucial in revealing these functions, providing insights into potential therapeutic targets for these diseases.
References:
1. Xiang, Wei, Lv, Hongwei, Xing, Fuxue, Yang, Wen, Wang, Hongyang. 2023. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. In Science advances, 9, eadi2465. doi:10.1126/sciadv.adi2465. https://pubmed.ncbi.nlm.nih.gov/38055816/
2. Feng, Xiaojun, Zhang, Lei, Xu, Suowen, Shen, Ai-Zong. 2019. ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review. In Progress in lipid research, 77, 101006. doi:10.1016/j.plipres.2019.101006. https://pubmed.ncbi.nlm.nih.gov/31499095/
3. Wen, Jun, Min, Xuejie, Shen, Mengqin, Liu, Jianjun, Zhao, Xiaoping. 2019. ACLY facilitates colon cancer cell metastasis by CTNNB1. In Journal of experimental & clinical cancer research : CR, 38, 401. doi:10.1186/s13046-019-1391-9. https://pubmed.ncbi.nlm.nih.gov/31511060/
4. Li, Kai, Zhang, Kaini, Wang, Hai, Liang, Xiubin, Su, Dongming. 2020. Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice. In Metabolism: clinical and experimental, 114, 154349. doi:10.1016/j.metabol.2020.154349. https://pubmed.ncbi.nlm.nih.gov/32888949/
5. Gao, Wenbin, Zhang, Liping, Li, Ziru, Mulholland, Michael W, Zhang, Weizhen. 2023. Nuclear Acly protects the liver from ischemia-reperfusion injury. In Hepatology (Baltimore, Md.), 80, 1087-1103. doi:10.1097/HEP.0000000000000692. https://pubmed.ncbi.nlm.nih.gov/37983829/
6. Schulz-Kuhnt, Anja, Rühle, Katharina, Javidmehr, Asal, Neurath, Markus F, Atreya, Imke. 2024. ATP citrate lyase (ACLY)-dependent immunometabolism in mucosal T cells drives experimental colitis in vivo. In Gut, 73, 601-612. doi:10.1136/gutjnl-2023-330543. https://pubmed.ncbi.nlm.nih.gov/38176897/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
